Insider · CIK 0001262325

Aguiar Eric

CIK 0001262325 Name as filed on the most recent filing

Filed as Aguiar Eric (18)

26 transaction lines · from 18 filings · filed 2004-06-02 to 2020-12-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-12-16 S, Open-market sale Invitae CorpNVTA 2 lines 510,003, disposed Open Form 4 filing 0000899243-20-034578
2020-11-16 S, Open-market sale Invitae CorpNVTA 2 lines 1,395,711, disposed Open Form 4 filing 0001501134-20-000081
2020-07-15 S, Open-market sale Invitae CorpNVTA 2 lines 339,853, disposed Open Form 4 filing 0000899243-20-019412
2020-01-22 S, Open-market sale Biohaven Pharmaceutical Holding Co Ltd.BHVN 5 lines 114,152, disposed Open Form 4 filing 0001562180-20-000570
2020-01-09 S, Open-market sale Biohaven Pharmaceutical Holding Co Ltd.BHVN 1,691,700, disposed Open Form 4 filing 0001562180-20-000347
2019-12-16 S, Open-market sale Biohaven Pharmaceutical Holding Co Ltd.BHVN 194,985, disposed Open Form 4 filing 0001689813-19-000118
2019-12-09 S, Open-market sale Biohaven Pharmaceutical Holding Co Ltd.BHVN 224,411, disposed Open Form 4 filing 0001689813-19-000116
2019-11-22 S, Open-market sale Biohaven Pharmaceutical Holding Co Ltd.BHVN 69,050, disposed Open Form 4 filing 0001689813-19-000097
2019-11-20 S, Open-market sale Biohaven Pharmaceutical Holding Co Ltd.BHVN 351,234, disposed Open Form 4 filing 0001689813-19-000097
2019-09-11 S, Open-market sale Biohaven Pharmaceutical Holding Co Ltd.BHVN 450,000, disposed Open Form 4 filing 0001689813-19-000063
2019-07-03 P, Open-market purchase Eidos Therapeutics, Inc.EIDX 26,382,796, acquired Open Form 4 filing 0000899243-19-019339
2019-05-24 P, Open-market purchase Eidos Therapeutics, Inc.EIDX 28,622,779, acquired Open Form 4 filing 0000899243-19-015089
2018-11-27 S, Open-market sale Invitae CorpNVTA 135,000, disposed Open Form 4 filing 0000899243-18-029769
2016-11-18 P, Open-market purchase Invitae CorpNVTA 62,834, acquired Open Form 4 filing 0000899243-16-034048
2007-08-03 P, Open-market purchase Healthcare Acquisition CorpHAQ 957,500, acquired Open Form 4 filing 0001231919-07-000065
2007-08-03 P, Open-market purchase Activbiotics IncHAQ 957,500, acquired Open Form 4 filing 0001231919-07-000064
2007-04-12 P, Open-market purchase Advancis Pharmaceutical CorpAVNC 1,614,178, acquired Open Form 4 filing 0001231919-07-000029
2004-06-02 P, Open-market purchase Critical Therapeutics IncCRTX 2,499,700, acquired Open Form 4 filing 0001231919-04-000200
2004-06-02 P, Open-market purchase Critical Therapeutics IncCRTX 2,499,700, acquired Open Form 4 filing 0001231919-04-000175

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 18
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. AGUIAR ERIC, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001262325

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.